Research Evidence / Overview of Studies for Deflamol
This section provides an overview of the research that has explored the use of Deflamol, focusing on what types of studies were conducted, the outcomes measured, and where evidence limitations currently exist. We focus only on research and avoid any form of clinical advice or treatment recommendation.
Evidence for Minor Burns and Sunburn Studies
Research has explored the product in the context of minor, superficial skin injuries, including first-degree burns and mild to moderate sunburn. Researchers conducted short-term Randomized Controlled Trials (RCTs) and comparative observational studies to explore how the skin responded. The primary measures used in these trials were related to changes in skin redness (erythema), patient-reported outcomes describing perceived discomfort, and the time required for re-healing.
In these research settings, studies described the changes that were monitored in the observed populations. Research documented the measurements of skin redness over the study period when compared to initial baseline assessments. Findings describe patterns observed in outcomes related to physical discomfort during short-term follow-up, which typically lasted less than two weeks. This evidence contributes to the broader evidence landscape regarding short-term evaluation patterns.
The follow-up durations were limited, predominantly focusing on the acute phase of healing. There is limited information for long-term outcomes or how the skin recovers weeks or months after use. Furthermore, data are still emerging regarding its evaluation in more severe burn types, and the results apply only to the populations studied, which were generally healthy adults and adolescents.
Evidence for Superficial Wounds, Cuts, and Abrasions Research
Research exploring the product in the context of minor, superficial wounds like cuts and scrapes has been conducted using different study designs, including non-blinded prospective studies and post-marketing reports. Researchers examined outcomes related to visual assessment of wound closure rate and measurement of wound area reduction. These studies were mostly conducted during periods of increased symptom activity where healing patterns was observed in temporary physiological imbalance.
The available evidence comes from settings with varying baseline symptom levels. Findings describe patterns observed in the studies regarding the temporary closure and healing of small wounds. Research provides insight into short-term changes in the observed populations, and the studies monitored the skin's response over defined time intervals, usually 5 to 10 days.
This evidence is limited because it primarily relies on non-randomized designs and small sample sizes, which contributes to low certainty. Comparative evidence is limited regarding the evaluation against other commonly available topical products in controlled settings. The follow-up durations were limited, and subgroup findings are uncertain for specific wound characteristics or in individuals with slower healing rates.
Evidence for Diaper Rash Studies in Infants
For conditions characterized by fluctuating or episodic manifestations like diaper rash, research has focused on Comparative Efficacy Trials and open-label safety studies in the pediatric age group. These studies was evaluated in infants and toddlers (3–36 months) with mild to moderate contact dermatitis. Outcomes related to outcomes linked to inflammatory or irritative states were the primary focus, specifically measuring the reduction in rash severity scores and the time required for full resolution of the rash.
In these trials, studies described the changes that were monitored in the infants over the defined time intervals. The findings describe patterns observed in the rate of reduction in rash severity compared to baseline. This evidence contributes to understanding symptom patterns during the short, acute phase of the condition.
The research conducted to date focused on the presence of an existing rash. Data for certain groups remain insufficient, specifically for the product's use preventatively (prophylactically) to avoid the development of a rash. The follow-up durations were limited, and long-term outcomes are not fully established regarding repeated use or use in more severe, complicated cases of diaper rash.
Evidence for General Skin Irritation and Dryness
The product's use for general dry skin (xerosis) and mild irritation was evaluated in studies using crossover design studies and dermatological patch tests. These studies research examined outcomes related to physiological strain or stress, specifically measuring skin hydration and Transepidermal Water Loss (TEWL). Researchers also applied in studies examining patient-reported experiences related to skin softness and perceived discomfort (pruritus or itching).
Studies reported measurements of skin hydration metrics during the intermediate study period (2 to 4 weeks). Findings describe patterns observed in patient-reported outcomes where individuals documented reduced dryness and itching. This research documents short-term changes in skin moisture levels under controlled conditions.
The evidence quality varies across studies, and the data often relies heavily on subjective reports from the participants. Limited data are still emerging for individuals with pre-existing, more severe skin conditions like eczema or chronic dermatitis. Additionally, the comparative evidence is limited regarding how this product performs against a broad range of other available topical products in the market, as research is ongoing.
⏳ Long-Term Research and Durability of Observations
Most of the available evidence is based on short-term follow-up, typically lasting only a few days to a few weeks, depending on the indication studied. Research explores short-term symptom changes but does not extensively monitor outcomes beyond the initial evaluation phase.
The long-term outcomes are not fully established for any of the indications. There is limited information for long-term outcomes regarding the durability of the reported observations, nor is there comprehensive data on the outcomes of using the product continuously over extended time intervals (months or years). Current evidence focuses on episodic or acute changes rather than sustained, chronic skin conditions.
Evidence in Special Study Populations
Specific research exploring the product's use in certain subgroups is limited. While some studies have focused on infants for diaper rash, data for certain groups remain insufficient, such as pregnant or breastfeeding populations.
Research has explored the product for adults and adolescents, but the extent of evidence specifically evaluating the product in older adults with age-related skin thinning or other comorbidities is not extensive. Subgroup findings are uncertain for individuals with complex medical conditions, and results apply only to the populations studied in the original trials.
Evidence Gaps and Areas of Uncertainty
A review of the current evidence highlights several areas where certainty remains low and further research would be valuable. The reliance on short-term data is noted, meaning the long-term outcomes are not fully established.
Additionally, comparative evidence is limited for certain indications where the product was not directly contrasted with a wide range of other available topical products. Sample sizes were modest in several descriptive studies, and evidence quality varies across studies, particularly for superficial wounds. Research efforts are ongoing to fill these gaps and provide a more comprehensive understanding symptom patterns across all relevant populations and timeframes.
Key Studies & References
- Diaper rash - Symptoms & causes - Mayo Clinic (Clinical Guideline/Information on Treatment Outcomes)
